Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB2 harmonization project comparing three NGS panels J Ramos-Paradas, S Hernández-Prieto, D Lora, E Sanchez, A Rosado, ... Journal for ImmunoTherapy of Cancer 9 (5), 2021 | 24 | 2021 |
Selected polyphenols potentiate the apoptotic efficacy of glycolytic inhibitors in human acute myeloid leukemia cell lines. Regulation by protein kinase activities E de Blas, MC Estañ, M del Carmen Gómez de Frutos, J Ramos, ... Cancer Cell International 16, 1-16, 2016 | 17 | 2016 |
Comprehensive characterization of human lung large cell carcinoma identifies transcriptomic signatures with potential implications in response to immunotherapy J Ramos-Paradas, D Gómez-Sánchez, A Rosado, AC Ucero, I Ferrer, ... Journal of Clinical Medicine 11 (6), 1500, 2022 | 3 | 2022 |
Harmonization study of tumour mutational burden determination in non-small cell lung cancer (NSCLC) EM Garrido-Martin, J Ramos-Paradas, SH Prieto, E Sanchez, A Rosado, ... Annals of Oncology 30, v852, 2019 | 3 | 2019 |
Identification of predictive biomarkers of immunotherapy response in non-small cell lung cancer by multiparametric analysis JR Paradas, D Gomez-Sanchez, A Rosado, I Ferrer, N Carrizo, ... European Respiratory Journal 58 (suppl 65), 2021 | 1 | 2021 |
Enabling biomarkers of chromosomal instability for tumor only targeted gene panel sequencing D Gómez-Sánchez, JS Thompson, B Hernando, D García-López, ... Cancer Research 84 (6_Supplement), 7422-7422, 2024 | | 2024 |
Comprehensive characterization of human lung squamous cell carcinoma identifies high TFRC expression as a mark of poorly immunogenic tumours M Gutierrez Perez, J Ramos Paradas, D Gomez Sanchez, R Garcia Lujan, ... ANNALS OF ONCOLOGY 34, S739-S740, 2023 | | 2023 |
1280P Comprehensive characterization of human lung squamous cell carcinoma identifies high TFRC expression as a mark of poorly immunogenic tumours MG Pérez, JR Paradas, DG Sanchez, RG Lujan, J Zugazagoitia, ... Annals of Oncology 34, S739-S740, 2023 | | 2023 |
Comprehensive analysis of non-small cell lung cancer identifies molecular genotype-immunophenotype associations and candidate biomarkers predictive of response to immunotherapy J Ramos-Paradas, D Gomez-Sanchez, A Rosado, AC Ucero, N Carrizo, ... Cancer Research 82 (12_Supplement), 1245-1245, 2022 | | 2022 |
Interleukin-11 could be a novel therapeutic target for lung adenocarcinoma patients L Ojeda, C Cirauqui, S Molina-Pinelo, EM Garrido-Martín, ... Cancer Research 80 (16_Supplement), 5247-5247, 2020 | | 2020 |
Comprehensive multiparametric analysis of non-small cell lung cancer describes novel genotype-immunophenotype relationships and provides putative biomarker signatures of … J Ramos-Paradas, D Gomez-Sanchez, A Rosado, I Ferrer, N Carrizo, ... Cancer Research 80 (16), 2020 | | 2020 |